CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy, covering 2019-05-10 to 2019-05-10. Get the full timeline:
Most recent: Clinical Trial Update: CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies [Phase 1, Phase 2]